Insights on the Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global dual specificity tyrosine phosphorylation regulated kinase 1A market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dual-specificity tyrosine phosphorylation-regulated kinase 1A or DYRK1A is a eukaryotic serine-threonine protein kinase that belongs to the CMGC group and contributes to the development of several human malignancies and cognitive deficits that are observed in down syndrome and Alzheimer's disease. The major factor accelerating the growth of the market is the increasing prevalence of Alzheimer’s disease across the globe.
To Request a Sample of our Report on Dual Specificity
Tyrosine Phosphorylation Regulated Kinase 1A Market: https://www.omrglobal.com/request-sample/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-market
According to the Alzheimer's
Association, more than 6 million Americans of all ages have Alzheimer's.
Additionally, in 2021, an estimated 6.2 million Americans age 65 and older are
living with Alzheimer's dementia out of which 72% are aged 75 or older. Furthermore,
as per the same source, one in nine people age 65 and older or 11.3% has
Alzheimer's dementia. Moreover, almost two-thirds of Americans with Alzheimer's
are women. Apart from this, the number of people aged 65 and older with
Alzheimer’s dementia is estimated to grow to 12.7 million by 2050. Hence, the
increasing Alzheimer's disease is resulting increased prevalence of cognitive
deficits and human malignancies which in turn is driving the growth of the
market.
Some major players operating in
the market include Pharmasum Therapeutics AS, Carna Biosciences Inc., and
NeuroNascent Inc., among others. The market players are contributing
significantly to the growth of the market by the adoption of various strategies
including mergers & acquisitions, geographical expansion, partnerships and
collaborations, and new product launches, to stay competitive in the market.
For instance, in September 2021, Brickell Biotech, Inc. announced that it has
entered into a definitive agreement with Voronoi Inc. The agreement was aimed
to grant Brickell exclusive, global rights to research, develop and
commercialize novel therapeutics generated from a proprietary DYRK1A inhibitor
platform.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
•
By Type
•
By Application
Regions Covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape-
Pharmasum Therapeutics AS, Carna Biosciences Inc., and NeuroNascent Inc., among
others.
(Get 15% Discount on Buying this Report)[mj1]
A
full Report of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A
Market is Available @
https://www.omrglobal.com/industry-reports/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-market
Global Dual Specificity Tyrosine Phosphorylation
Regulated Kinase 1A Market Report by Segment
By Type
• PST-900
• NNI-351
• FX-9847
• Others
By Application
• Colon Cancer
• Down Syndrome
• Lung Cancer
• Pancreatic Cancer
• Others
Global Dual Specificity Tyrosine Phosphorylation
Regulated Kinase 1A Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert research
analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment